Trials / Conditions / Severe COVID-19 Pneumonia
Severe COVID-19 Pneumonia
4 registered clinical trials studyying Severe COVID-19 Pneumonia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19 NCT04924829 | Hospital Italiano de Buenos Aires | — |
| Completed | A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus NCT04880694 | Grand Medical Pty Ltd. | Phase 2 |
| Completed | ANTIcoagulation in Severe COVID-19 Patients NCT04808882 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia NCT04333420 | InflaRx GmbH | Phase 2 / Phase 3 |